Trial of antibiotic restraint in presumed pneumonia: A Surgical Infection Society multicenter pilot-Reference-Cited by-同舟云学术

Trial of antibiotic restraint in presumed pneumonia: A Surgical Infection Society multicenter pilot

Published:2022-11-18 Issue:2 Volume:94 Page:232-240
ISSN:2163-0763
Container-title:Journal of Trauma and Acute Care Surgery
language:en
Short-container-title:J Trauma Acute Care Surg

Author:

Guidry Christopher A.,Beyene Robel T.,Watson Christopher M.,Sawyer Robert G.,Chollet-Hinton Lynn,Simpson Steven Q.,Atchison Leanne,Derickson Michael,Cooper Lindsey C.,Pennington G. Patton,VandenBerg Sheri,Halimeh Bachar N.,O'Dell Jacob C.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Critical Care and Intensive Care Medicine,Surgery

Reference41 articles.

1. Prevalence and outcomes of infection among patients in intensive care units in 2017;JAMA,2020

2. Risk factors for infection and evaluation of Sepsis-3 in patients with trauma;Am J Surg,2019

3. Ventilator-associated pneumonia in trauma patients: different criteria, different rates;Surg Infect (Larchmt),2016

4. Non-utility of sepsis scores for identifying infection in surgical intensive care unit patients;Am J Surg,2019

5. Evaluation of the infection-related ventilator-associated events algorithm for ventilator-associated pneumonia surveillance in a trauma population;Respir Care,2016

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Desirability of Outcome Ranking and Response Adjusted for Antibiotic Risk (DOOR/RADAR) Post Hoc Analysis Supports Equipoise for Antibiotic Initiation Strategies in Intensive Care Unit-Acquired Pneumonia;Surgical Infections;2024-04-01

2. Provider Perceptions of Antibiotic Initiation Strategies for Hospital-Acquired Pneumonia;Surgical Infections;2024-03-01

3. Immediate vs. culture-initiated antibiotic therapy in suspected non-severe ventilator-associated pneumonia: a before–after study (DELAVAP);Annals of Intensive Care;2024-02-27

4. Risk factors for COVID-19 infection in people with 4th dose of bivalent mRNA vaccines in general medicine from October 2022 to February 2023;Archives of Community Medicine and Public Health;2023-05-30